XPH vs. FBGRX
Compare and contrast key facts about SPDR S&P Pharmaceuticals ETF (XPH) and Fidelity Blue Chip Growth Fund (FBGRX).
XPH is a passively managed fund by State Street that tracks the performance of the S&P Pharmaceuticals Select Industry Index. It was launched on Jun 19, 2006. FBGRX is managed by Fidelity. It was launched on Dec 31, 1987.
Performance
XPH vs. FBGRX - Performance Comparison
Loading graphics...
XPH vs. FBGRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XPH SPDR S&P Pharmaceuticals ETF | -2.19% | 31.60% | 4.94% | 2.97% | -9.83% | -10.54% | 14.68% | 25.61% | -15.32% | 12.05% |
FBGRX Fidelity Blue Chip Growth Fund | -7.12% | 19.91% | 39.77% | 55.61% | -38.45% | 22.64% | 62.20% | 33.43% | 1.02% | 36.01% |
Returns By Period
In the year-to-date period, XPH achieves a -2.19% return, which is significantly higher than FBGRX's -7.12% return. Over the past 10 years, XPH has underperformed FBGRX with an annualized return of 3.94%, while FBGRX has yielded a comparatively higher 19.08% annualized return.
XPH
- 1D
- 1.16%
- 1M
- -4.82%
- YTD
- -2.19%
- 6M
- 13.09%
- 1Y
- 30.74%
- 3Y*
- 11.47%
- 5Y*
- 3.03%
- 10Y*
- 3.94%
FBGRX
- 1D
- 4.54%
- 1M
- -5.07%
- YTD
- -7.12%
- 6M
- -4.04%
- 1Y
- 26.78%
- 3Y*
- 26.54%
- 5Y*
- 11.74%
- 10Y*
- 19.08%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
XPH vs. FBGRX - Expense Ratio Comparison
XPH has a 0.35% expense ratio, which is lower than FBGRX's 0.79% expense ratio.
Return for Risk
XPH vs. FBGRX — Risk / Return Rank
XPH
FBGRX
XPH vs. FBGRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and Fidelity Blue Chip Growth Fund (FBGRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XPH | FBGRX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.28 | 1.13 | +0.15 |
Sortino ratioReturn per unit of downside risk | 1.80 | 1.73 | +0.08 |
Omega ratioGain probability vs. loss probability | 1.23 | 1.25 | -0.02 |
Calmar ratioReturn relative to maximum drawdown | 1.97 | 2.00 | -0.03 |
Martin ratioReturn relative to average drawdown | 6.54 | 7.92 | -1.38 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| XPH | FBGRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.28 | 1.13 | +0.15 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.15 | 0.47 | -0.33 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.18 | 0.81 | -0.63 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.65 | -0.27 |
Correlation
The correlation between XPH and FBGRX is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
XPH vs. FBGRX - Dividend Comparison
XPH's dividend yield for the trailing twelve months is around 0.68%, less than FBGRX's 2.05% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XPH SPDR S&P Pharmaceuticals ETF | 0.68% | 0.83% | 1.58% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% |
FBGRX Fidelity Blue Chip Growth Fund | 2.05% | 1.90% | 5.95% | 0.93% | 0.57% | 8.73% | 6.40% | 3.70% | 6.32% | 4.23% | 4.05% | 5.30% |
Drawdowns
XPH vs. FBGRX - Drawdown Comparison
The maximum XPH drawdown since its inception was -48.03%, smaller than the maximum FBGRX drawdown of -58.64%. Use the drawdown chart below to compare losses from any high point for XPH and FBGRX.
Loading graphics...
Drawdown Indicators
| XPH | FBGRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.03% | -58.64% | +10.61% |
Max Drawdown (1Y)Largest decline over 1 year | -13.15% | -13.89% | +0.74% |
Max Drawdown (5Y)Largest decline over 5 years | -31.63% | -43.08% | +11.45% |
Max Drawdown (10Y)Largest decline over 10 years | -35.97% | -43.08% | +7.11% |
Current DrawdownCurrent decline from peak | -6.21% | -8.68% | +2.47% |
Average DrawdownAverage peak-to-trough decline | -17.37% | -12.58% | -4.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.96% | 3.51% | +0.45% |
Volatility
XPH vs. FBGRX - Volatility Comparison
SPDR S&P Pharmaceuticals ETF (XPH) has a higher volatility of 9.05% compared to Fidelity Blue Chip Growth Fund (FBGRX) at 7.83%. This indicates that XPH's price experiences larger fluctuations and is considered to be riskier than FBGRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| XPH | FBGRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.05% | 7.83% | +1.22% |
Volatility (6M)Calculated over the trailing 6-month period | 16.40% | 14.08% | +2.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.50% | 24.98% | -0.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.57% | 24.93% | -4.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.22% | 23.63% | -1.41% |